170874-56-3

Upstream product

• 1694-92-4 2-Nitrobenzenesulfonyl chloride 
• 6298-19-7 2-chloro-3-aminopyridine 
• 546069-52-7 N-(2-chloro-3-pyridyl)-2-nitrobenzenesulfonamide 
• 733739-23-6 N-(2-chloro-3-pyridyl)-N-methyl-2-nitrobenzenesulfonamide 

Downstream Products

• 871714-91-9 1-[2-(4-phenol)ethyl]-5-methyl-1,5-dihydropyrido[3,2-c][1,2,5]benzothiadiazepine 6,6-dioxide 
• 733739-70-3 1-{2-[4-(Benzyloxy)phenyl]ethyl}-5-methyl-1,5-dihydropyrido[3,2-c][1,2,5]benzothiadiazepine 6,6-dioxide 
• 733739-20-3 2-acetylamino-N-(2-chloro-3-pyridyl)-N-methylbenzenesulfonamide 

Relevant academic research and scientific papers

Novel tricyclic azepine derivatives, method for production thereof and pharmaceutical compositions comprising the same

A compound of formula (I): wherein: represents benzo or pyrido, optionally fused in the 2-3, 3-4 or 4-5 position to a phenyl, (C4-C8)cycloalkyl or heterocyclic group, which may be optionally substituted, W represents X—Y or Y—X, wher

Novel benzopyridothiadiazepines as potential active antitumor agents

The synthesis of novel thiadiazepine derivatives, that could be considered as constraint analogues of E-7010, are reported. These molecules were evaluated for their antiproliferative activity toward the murine L1210 leukemia cell line. Flow cytometric studies performed on L1210 cells with the most cytotoxic compounds showed an accumulation of the cells in the G2/M phases of the cell cycle with a significant percentage of tetraploid cells (8N DNA content). Submicromolar cytotoxicities were observed with compounds 2b, 4b, 4e, 4g, and 4i. Two of them, compounds 2b and 4b, were found to be potent inhibitors of tubulin polymerization with IC50 of respectively 3.8 and 2.4 μM compared to 2.4 μM for desoxypodophyllotoxin. A 4-methoxyphenylethyl substitution on the pyridinyl nitrogen of the benzopyridothiadiazepine was found to be essential for the antiproliferative activity. The in vitro activities of compounds 2b and 4b make benzopyridothiadiazepine dioxides a promising new class of tubulin binders which warrant further in vivo evaluation.